OBLITERATIVE BRONCHIOLITIS side effect
What is OBLITERATIVE BRONCHIOLITIS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
OBLITERATIVE BRONCHIOLITIS and Recently Reported Side Effects
OBLITERATIVE BRONCHIOLITIS and 15 most Active Side Effect polls
OBLITERATIVE BRONCHIOLITIS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with OBLITERATIVE BRONCHIOLITIS
ARIMIDEX BUSULFAN CARBOPLATIN CETUXIMAB CORTICOSTEROIDS CYCLOSPORINE ENBREL EPIRUBICIN FLUDARA FLUOROURACIL GLEEVEC LOPRESSOR MABTHERA OCRELIZUMAB PENICILLAMINE PENTASA PROGRAF REMICADE RITUXAN SANDIMMUNE THYMOGLOBULIN VELCADESandimmune Side Effects Report #5661569-2
Health Professional from GERMANY reported SANDIMMUNE problem on Feb 29, 2008. Male patient, 35 years of age, was diagnosed with lung transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pneumonia, sepsis, . SANDIMMUNE dosage: unknown. During the same period patient was treated with CELLCEPT, DECORTIN. Patient recovered.
Sandimmune Side Effects Report #5661588-6
SANDIMMUNE problem was reported by a Health Professional from GERMANY on Feb 29, 2008. Female patient, 50 years of age, was diagnosed with lung transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . SANDIMMUNE dosage: unknown. During the same period patient was treated with CELLCEPT, DECORTIN. Patient recovered.
Gleevec Side Effects Report #5610722-2
Physician from JAPAN reported GLEEVEC problem on Jan 23, 2008. Male patient, 64 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . GLEEVEC dosage: 400 MG/D. Patient recovered.
Cetuximab Side Effects Report #5632049-5
CETUXIMAB problem was reported by a Health Professional from GERMANY on Feb 13, 2008. Female patient, 61 years of age, was diagnosed with squamous cell carcinoma and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pyrexia, respiratory failure, . CETUXIMAB dosage: unknown. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.
Gleevec Side Effects Report #5562827-2
Physician from JAPAN reported GLEEVEC problem on Dec 05, 2007. Male patient, 64 years of age, was diagnosed with gastrointestinal stromal tumour and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . GLEEVEC dosage: 400 MG/D. Patient recovered.
Ocrelizumab Side Effects Report #5507151-9
OCRELIZUMAB problem was reported by a Physician from UNITED KINGDOM on Oct 24, 2007. Male patient, weighting 191.8 lb, was diagnosed with non-hodgkin's lymphoma and was treated with OCRELIZUMAB. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pulmonary embolism, . OCRELIZUMAB dosage: 200 MG/M2, Q3W. During the same period patient was treated with MABTHERA, ALLOPURINOL, CHLORAMBUCIL, FLUDARABINE PHOSPHATE. Patient was hospitalized and became disabled. Patient died on 05/25/2006.
Gleevec Side Effects Report #5511574-1
Physician from JAPAN reported GLEEVEC problem on Oct 30, 2007. Male patient, 60 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . GLEEVEC dosage: 400 MG/D. Patient recovered.
Enbrel Side Effects Report #5523433-9
ENBREL problem was reported by a Physician from UNITED KINGDOM on Nov 12, 2007. Female patient, 36 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5523818-0
Consumer or non-health professional from JAPAN reported BUSULFAN problem on Nov 05, 2007. Female patient, child 1 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, respiratory failure, thrombotic microangiopathy, . BUSULFAN dosage: 2.8 ML; QD; IV, 4.0 ML; QD; IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, CLONAEPAM, METHOTREXATE, TARCOLIMUS, CYCLOSPORINE. Patient died on 06/25/2007.
Cyclosporine Side Effects Report #5523942-2
CYCLOSPORINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2007. Female patient was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with SIROLIMUS, AZATHIOPRINE, METHYLPREDNISOLONE. Patient recovered.
Fluorouracil Side Effects Report #5527421-8
Health Professional from UNITED STATES reported FLUOROURACIL problem on Nov 12, 2007. Female patient, 37 years of age, was diagnosed with colon cancer and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, respiratory failure, . FLUOROURACIL dosage: 425 MG/M2/D, DAYS 1-5 Q28D X6, INTRAVENOUS. During the same period patient was treated with PANTOPRAZOLE, GLIPIZIDE, IRBESARTAN, HYDROCHLOROTHIAZIDE. Patient died.
Fluorouracil Side Effects Report #5478193-7
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2007. Female patient, 37 years of age, was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . FLUOROURACIL dosage: DOSE: 425 MG/M**2 ON DAYS 1-5. During the same period patient was treated with PANTOPRAZOLE, GLIPIZIDE, IRBESARTAN. Patient was hospitalized. Patient died.
Lopressor Side Effects Report #5502597-7
Physician from GERMANY reported LOPRESSOR problem on Oct 22, 2007. Female patient, 82 years of age, was diagnosed with supraventricular tachycardia and was treated with LOPRESSOR. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pneumonia, . LOPRESSOR dosage: 100 MG/DAY. During the same period patient was treated with AMIODARONE, TORVAST, ASPIRIN. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5757194-5
CETUXIMAB problem was reported by a Consumer or non-health professional from IRELAND on May 29, 2008. Female patient, 61 years of age, was diagnosed with head and neck cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pyrexia, respiratory failure, . CETUXIMAB dosage: 2MG/ML. LAST INFUSION ON 28JAN08. PERMANENTLY DISCONTINUED ON 04FEB08. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died.
Cetuximab Side Effects Report #5747301-2
Consumer or non-health professional from IRELAND reported CETUXIMAB problem on May 19, 2008. Female patient, 61 years of age, was diagnosed with head and neck cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pyrexia, respiratory failure, . CETUXIMAB dosage: 2MG/ML. LAST INFUSION ON 28JAN08. PERMANENTLY DISCONTINUED ON 04FEB08. During the same period patient was treated with CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died.
Prograf Side Effects Report #5356563-5
PROGRAF problem was reported by a Physician from JAPAN on May 28, 2007. Male patient, child 5 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . PROGRAF dosage: 0.02 MG/KG, CONTINUOUS, IV DRIP. During the same period patient was treated with PREDNISOLONE. Patient died.
Prograf Side Effects Report #5363093-3
Physician from JAPAN reported PROGRAF problem on May 31, 2007. Male patient, child 5 years of age, was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . PROGRAF dosage: 0.02 MG/KG, CONTINUOUS; IV DRIP. During the same period patient was treated with PREDNISOLONE. Patient died.
Pentasa Side Effects Report #5330577-3
PENTASA problem was reported by a Health Professional from FRANCE on May 02, 2007. Male patient, 17 years of age, was diagnosed with colitis ulcerative and was treated with PENTASA. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pancreatitis, pulmonary granuloma, . PENTASA dosage: unknown. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5288321-4
Health Professional from SPAIN reported REMICADE problem on Mar 21, 2007. Female patient, 64 years of age, was diagnosed with rheumatoid arthritis and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . REMICADE dosage: unknown. Patient died on 11/11/2001.
Corticosteroids Side Effects Report #5289434-3
CORTICOSTEROIDS problem was reported by a Health Professional from UNITED STATES on Mar 27, 2007. Female patient, 56 years of age, was diagnosed with lung transplant and was treated with CORTICOSTEROIDS. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, . CORTICOSTEROIDS dosage: unknown. During the same period patient was treated with CYTOSTATIC AGENT, CYCLOSPORINE. Patient recovered.
Mabthera Side Effects Report #5295530-7
Health Professional from SWEDEN reported MABTHERA problem on Mar 20, 2007. Male patient, 60 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pulmonary embolism, . MABTHERA dosage: unknown. Patient died on 05/25/2006.
Arimidex Side Effects Report #5653614-5
ARIMIDEX problem was reported by a Consumer or non-health professional from BRAZIL on Feb 27, 2008. Female patient, 76 years of age, weighting 123.5 lb, was diagnosed with breast cancer, hypothyroidism, hypertension and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: hypersensitivity, obliterative bronchiolitis, pneumonia, . ARIMIDEX dosage: unknown. During the same period patient was treated with TAMOXIFEN, PURAN T. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5537261-1
Physician from UNITED KINGDOM reported RITUXAN problem on Nov 27, 2007. Male patient, 25 years of age, was diagnosed with lymphoproliferative disorder and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: cryptogenic organising pneumonia, obliterative bronchiolitis, . RITUXAN dosage: unknown. During the same period patient was treated with ALEMTUZUMAB, CYCLOSPORINE, FLUDARABINE PHOSPHATE, MELPHALAN. Patient died.
Enbrel Side Effects Report #5482286-8
ENBREL problem was reported by a Physician from SWITZERLAND on Oct 02, 2007. Female patient, 68 years of age, was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: obliterative bronchiolitis, pleural effusion, systemic lupus erythematosus, . ENBREL dosage: 50 MG PER WEEK. During the same period patient was treated with METHOTREXATE, FOLIC ACID. Patient was hospitalized. Patient recovered.
Rituxan Side Effects Report #5376453-1
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on June 22, 2007. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, obliterative bronchiolitis, . RITUXAN dosage: 375 MG/M2, UNK. Patient recovered.
Rituxan Side Effects Report #5382944-X
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2007. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, obliterative bronchiolitis, . RITUXAN dosage: 375 MG/M2, UNK. Patient recovered.
Rituxan Side Effects Report #5376453-1
Consumer or non-health professional from UNITED STATES reported RITUXAN problem on June 22, 2007. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, obliterative bronchiolitis, . RITUXAN dosage: 375 MG/M2, UNK. Patient recovered.
Rituxan Side Effects Report #5382944-X
RITUXAN problem was reported by a Consumer or non-health professional from UNITED STATES on June 22, 2007. Male patient, 62 years of age, was diagnosed with mantle cell lymphoma and was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, obliterative bronchiolitis, . RITUXAN dosage: 375 MG/M2, UNK. Patient recovered.
Fludara Side Effects Report #5291211-4
Consumer or non-health professional from JAPAN reported FLUDARA problem on Mar 30, 2007. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, obliterative bronchiolitis, pneumonia, po2 decreased, respiratory failure, . FLUDARA dosage: 30 MG, CYCLE X 5D. During the same period patient was treated with RITUXAN. Patient died on 03/12/2007.
Fludara Side Effects Report #5298174-6
FLUDARA problem was reported by a Consumer or non-health professional from JAPAN on Apr 10, 2007. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, obliterative bronchiolitis, pneumonia, po2 decreased, respiratory failure, . FLUDARA dosage: 30 MG, CYCLE X 5D. During the same period patient was treated with RITUXAN. Patient died on 03/12/2007.
Fludara Side Effects Report #5253452-1
Physician from JAPAN reported FLUDARA problem on Feb 16, 2007. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, obliterative bronchiolitis, respiratory failure, . FLUDARA dosage: unknown. During the same period patient was treated with RITUXAN. Patient recovered.
Carboplatin Side Effects Report #5671623-7
CARBOPLATIN problem was reported by a Physician from AUSTRIA on Mar 03, 2008. Male patient, child 5 years of age, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, obliterative bronchiolitis, pulmonary mass, . CARBOPLATIN dosage: 4 X 300 MG/M2. During the same period patient was treated with ETOPOSIDE, AUTOLOGOUS TRANSPLANTATION. Patient recovered.
Cyclosporine Side Effects Report #5682277-8
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on Mar 19, 2008. Male patient, child 12 years of age, was diagnosed with prophylaxis against graft versus host disease and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: bronchopulmonary aspergillosis, graft versus host disease in lung, obliterative bronchiolitis, pancytopenia, rash, thrombotic microangiopathy, . CYCLOSPORINE dosage: unknown. During the same period patient was treated with METHYLPREDNISOLONE, METHOTREXATE, TACROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, CYCLOPHOSPHAMIDE. Patient died.
Arimidex Side Effects Report #5599977-0
ARIMIDEX problem was reported by a Consumer or non-health professional from BRAZIL on Jan 18, 2008. Female patient, 76 years of age, weighting 123.5 lb, was diagnosed with breast cancer and was treated with ARIMIDEX. After drug was administered, patient experienced the following problems/side effects: dermatitis allergic, hypersensitivity, obliterative bronchiolitis, pneumonia, . ARIMIDEX dosage: unknown. During the same period patient was treated with TAMOXIFEN. Patient was hospitalized. Patient recovered.
Gleevec Side Effects Report #5566137-9
Physician from JAPAN reported GLEEVEC problem on Dec 10, 2007. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, obliterative bronchiolitis, . GLEEVEC dosage: 400 MG/D. Patient was hospitalized and became disabled. Patient recovered.
Thymoglobulin Side Effects Report #5423755-6
THYMOGLOBULIN problem was reported by a Health Professional from UNITED STATES on July 15, 2004. Male patient, 13 years of age, was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, graft versus host disease, obliterative bronchiolitis, obstructive airways disorder, . THYMOGLOBULIN dosage: unknown. Patient died on 07/06/2004.
Thymoglobulin Side Effects Report #5423755-6
Health Professional from UNITED STATES reported THYMOGLOBULIN problem on July 15, 2004. Male patient, 13 years of age, was treated with THYMOGLOBULIN. After drug was administered, patient experienced the following problems/side effects: bilirubin conjugated increased, graft versus host disease, obliterative bronchiolitis, obstructive airways disorder, . THYMOGLOBULIN dosage: unknown. Patient died on 07/06/2004.
Gleevec Side Effects Report #5734176-0
GLEEVEC problem was reported by a Physician from JAPAN on Apr 28, 2008. Male patient, 66 years of age, weighting 154.3 lb, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, obliterative bronchiolitis, . GLEEVEC dosage: 400 MG/D. Patient was hospitalized and became disabled. Patient recovered.
Velcade Side Effects Report #5330627-4
Physician from NETHERLANDS reported VELCADE problem on May 04, 2007. Female patient, 60 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: lung infection pseudomonal, neuropathy, obliterative bronchiolitis, pulmonary embolism, . VELCADE dosage: unknown. During the same period patient was treated with THALIDOMIDE, PREDNISONE. Patient was hospitalized. Patient recovered.
Fludara Side Effects Report #5286810-X
FLUDARA problem was reported by a Consumer or non-health professional from JAPAN on Mar 27, 2007. Female patient, 54 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with FLUDARA. After drug was administered, patient experienced the following problems/side effects: dyspnoea, infection, obliterative bronchiolitis, po2 decreased, respiratory failure, . FLUDARA dosage: unknown. During the same period patient was treated with RITUXAN. Patient died on 03/14/2007.
Epirubicin Side Effects Report #5313004-1
Health Professional from FRANCE reported EPIRUBICIN HYDROCHLORIDE problem on Apr 19, 2007. Female patient, 41 years of age, was diagnosed with breast cancer and was treated with EPIRUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: cough, dyspnoea, obliterative bronchiolitis, . EPIRUBICIN HYDROCHLORIDE dosage: unknown. During the same period patient was treated with ENDOXAN, PRIMPERAN, ZOPHREN, FLUOROURACIL, METHYLPREDNISOLONE. Patient was hospitalized. Patient recovered.
Prograf Side Effects Report #5282410-6
PROGRAF problem was reported by a Physician from FRANCE on Mar 08, 2007. Male patient, 57 years of age, weighting 119.0 lb, was diagnosed with renal transplant, pneumocystis jiroveci pneumonia and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: bronchitis chronic, interstitial lung disease, obliterative bronchiolitis, overdose, pseudomonas infection, pulmonary hypertension, pyrexia, tachycardia, . PROGRAF dosage: unknown. During the same period patient was treated with BACTRIM DS, KARDEGIC, OMEPRAZOLE, LASIX, CELLCEPT, CORTICOSTEROIDS, NOVONORM. Patient was hospitalized and became disabled. Patient recovered.
Penicillamine Side Effects Report #5283998-1
Physician from JAPAN reported PENICILLAMINE problem on Mar 23, 2007. Female patient, 57 years of age, was diagnosed with arthritis and was treated with PENICILLAMINE. After drug was administered, patient experienced the following problems/side effects: bronchial obstruction, lymphocytic infiltration, obliterative bronchiolitis, . PENICILLAMINE dosage: 200MG PO QD. Patient was hospitalized. Patient recovered.